Wang Xueying, Zhou Yang, Liu Linlin, Ma Jinmin, Wu Honglong, Zhao Lijian, Chen Weijun, Li Shengwen Calvin, Ran Qian, Li Zhongjun
Lab Medicine Center, Lab of Radiation Biology, State Key Laboratory of Trauma, Burn and Combined Injury, The Second Affiliated Hospital, Army Medical University, Chongqing 400037, China.
BGI PathoGenesis Pharmaceutical Technology, BGI-Shenzhen, Shenzhen 518083, China.
Blood Genom. 2020;4(2):96-107. doi: 10.46701/BG.2020022020120.
Coronavirus disease 2019 (COVID-19) has become a global pandemic with a high rate of transmission. Currently, there is a lack of vaccines and specific drugs for this newly-emerged virus. Timely diagnosis and treatment, as well as isolation of patients and virus carriers, contribute to the effective prevention and control of this epidemic. This review focuses on early stage COVID-19 diagnosis methods and strategies, highlighting the guiding role of laboratory indicators on treatment strategy formulation, and prognosis assessments.
2019冠状病毒病（COVID-19）已成为一种传播率很高的全球大流行病。目前，针对这种新出现的病毒缺乏疫苗和特效药物。及时诊断和治疗，以及隔离患者和病毒携带者，有助于有效防控这一疫情。本综述重点关注COVID-19的早期诊断方法和策略，突出实验室指标在治疗策略制定和预后评估方面的指导作用。
